

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 7.81321646 |
| 2 | drug catabolic process (GO:0042737) | 7.53732058 |
| 3 | glyoxylate metabolic process (GO:0046487) | 7.52265153 |
| 4 | fatty acid elongation (GO:0030497) | 7.48553273 |
| 5 | ensheathment of neurons (GO:0007272) | 6.92105087 |
| 6 | axon ensheathment (GO:0008366) | 6.92105087 |
| 7 | myelination (GO:0042552) | 6.87359280 |
| 8 | epoxygenase P450 pathway (GO:0019373) | 6.86032112 |
| 9 | negative regulation of fibrinolysis (GO:0051918) | 6.75092493 |
| 10 | regulation of fibrinolysis (GO:0051917) | 6.67382505 |
| 11 | myelin maintenance (GO:0043217) | 6.55384945 |
| 12 | cellular glucuronidation (GO:0052695) | 6.36602748 |
| 13 | omega-hydroxylase P450 pathway (GO:0097267) | 6.21534854 |
| 14 | uronic acid metabolic process (GO:0006063) | 6.06812716 |
| 15 | glucuronate metabolic process (GO:0019585) | 6.06812716 |
| 16 | regulation of protein activation cascade (GO:2000257) | 5.97743465 |
| 17 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.92052917 |
| 18 | L-phenylalanine metabolic process (GO:0006558) | 5.92052917 |
| 19 | negative regulation of cholesterol transport (GO:0032375) | 5.85447953 |
| 20 | negative regulation of sterol transport (GO:0032372) | 5.85447953 |
| 21 | complement activation, alternative pathway (GO:0006957) | 5.80514736 |
| 22 | fibrinolysis (GO:0042730) | 5.72618041 |
| 23 | urea metabolic process (GO:0019627) | 5.61072826 |
| 24 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.52772979 |
| 25 | regulation of complement activation (GO:0030449) | 5.52643726 |
| 26 | bile acid biosynthetic process (GO:0006699) | 5.51251309 |
| 27 | drug metabolic process (GO:0017144) | 5.36239590 |
| 28 | ethanol oxidation (GO:0006069) | 5.29065808 |
| 29 | response to methylmercury (GO:0051597) | 5.16108268 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 5.11450052 |
| 31 | bile acid metabolic process (GO:0008206) | 5.04661255 |
| 32 | serine family amino acid catabolic process (GO:0009071) | 5.01573622 |
| 33 | oxidative demethylation (GO:0070989) | 4.99543895 |
| 34 | amino-acid betaine metabolic process (GO:0006577) | 4.96179937 |
| 35 | blood coagulation, intrinsic pathway (GO:0007597) | 4.92462706 |
| 36 | protein carboxylation (GO:0018214) | 4.85411201 |
| 37 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.85411201 |
| 38 | phenylpropanoid metabolic process (GO:0009698) | 4.74577618 |
| 39 | urea cycle (GO:0000050) | 4.64859678 |
| 40 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.62356684 |
| 41 | negative regulation of neurotransmitter transport (GO:0051589) | 4.61759547 |
| 42 | phospholipid efflux (GO:0033700) | 4.57584067 |
| 43 | aromatic amino acid family catabolic process (GO:0009074) | 4.55239317 |
| 44 | negative regulation of protein localization to cell surface (GO:2000009) | 4.51664194 |
| 45 | regulation of triglyceride catabolic process (GO:0010896) | 4.50586563 |
| 46 | regulation of collateral sprouting (GO:0048670) | 4.44939715 |
| 47 | bile acid and bile salt transport (GO:0015721) | 4.37863659 |
| 48 | glycine metabolic process (GO:0006544) | 4.37327053 |
| 49 | establishment of mitochondrion localization (GO:0051654) | 4.33452815 |
| 50 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.33319801 |
| 51 | cholesterol biosynthetic process (GO:0006695) | 4.32078822 |
| 52 | oligodendrocyte differentiation (GO:0048709) | 4.31850714 |
| 53 | amyloid precursor protein metabolic process (GO:0042982) | 4.30056168 |
| 54 | negative regulation of hemostasis (GO:1900047) | 4.28908583 |
| 55 | negative regulation of blood coagulation (GO:0030195) | 4.28908583 |
| 56 | L-amino acid import (GO:0043092) | 4.27746200 |
| 57 | regulation of cholesterol esterification (GO:0010872) | 4.19482642 |
| 58 | intestinal cholesterol absorption (GO:0030299) | 4.18728926 |
| 59 | ethanol metabolic process (GO:0006067) | 4.14922301 |
| 60 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.14545843 |
| 61 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.11799593 |
| 62 | triglyceride homeostasis (GO:0070328) | 4.10947238 |
| 63 | acylglycerol homeostasis (GO:0055090) | 4.10947238 |
| 64 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 4.07049242 |
| 65 | astrocyte development (GO:0014002) | 4.06663341 |
| 66 | * response to mercury ion (GO:0046689) | 4.00540864 |
| 67 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.98319347 |
| 68 | negative regulation of lipase activity (GO:0060192) | 3.98283341 |
| 69 | hormone catabolic process (GO:0042447) | 3.96534560 |
| 70 | S-adenosylmethionine metabolic process (GO:0046500) | 3.95329938 |
| 71 | high-density lipoprotein particle remodeling (GO:0034375) | 3.95279100 |
| 72 | negative regulation of coagulation (GO:0050819) | 3.91216853 |
| 73 | polyketide metabolic process (GO:0030638) | 3.90614120 |
| 74 | doxorubicin metabolic process (GO:0044598) | 3.90614120 |
| 75 | daunorubicin metabolic process (GO:0044597) | 3.90614120 |
| 76 | alkaloid metabolic process (GO:0009820) | 3.86822813 |
| 77 | cholesterol efflux (GO:0033344) | 3.85081494 |
| 78 | regulation of plasminogen activation (GO:0010755) | 3.84760553 |
| 79 | import into cell (GO:0098657) | 3.83531473 |
| 80 | protein activation cascade (GO:0072376) | 3.83185722 |
| 81 | negative regulation of wound healing (GO:0061045) | 3.83156192 |
| 82 | sterol biosynthetic process (GO:0016126) | 3.83098886 |
| 83 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.75313375 |
| 84 | macromolecular complex remodeling (GO:0034367) | 3.75242445 |
| 85 | plasma lipoprotein particle remodeling (GO:0034369) | 3.75242445 |
| 86 | protein-lipid complex remodeling (GO:0034368) | 3.75242445 |
| 87 | response to lipoprotein particle (GO:0055094) | 3.75042321 |
| 88 | reverse cholesterol transport (GO:0043691) | 3.74424590 |
| 89 | regulation of lipoprotein metabolic process (GO:0050746) | 3.72449895 |
| 90 | alpha-linolenic acid metabolic process (GO:0036109) | 3.70352915 |
| 91 | eye photoreceptor cell differentiation (GO:0001754) | 3.67241775 |
| 92 | photoreceptor cell differentiation (GO:0046530) | 3.67241775 |
| 93 | steroid catabolic process (GO:0006706) | 3.64412331 |
| 94 | very long-chain fatty acid metabolic process (GO:0000038) | 3.62744122 |
| 95 | serine family amino acid metabolic process (GO:0009069) | 3.62030741 |
| 96 | asymmetric protein localization (GO:0008105) | 3.59300396 |
| 97 | peripheral nervous system axon ensheathment (GO:0032292) | 3.59205070 |
| 98 | myelination in peripheral nervous system (GO:0022011) | 3.59205070 |
| 99 | substantia nigra development (GO:0021762) | 3.56361578 |
| 100 | positive regulation of blood coagulation (GO:0030194) | 3.56136747 |
| 101 | positive regulation of hemostasis (GO:1900048) | 3.56136747 |
| 102 | apical protein localization (GO:0045176) | 3.55733670 |
| 103 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.54931157 |
| 104 | isoprenoid biosynthetic process (GO:0008299) | 3.54688294 |
| 105 | sodium-independent organic anion transport (GO:0043252) | 3.54558277 |
| 106 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.52363447 |
| 107 | acute-phase response (GO:0006953) | 3.51851088 |
| 108 | flavonoid metabolic process (GO:0009812) | 3.51733543 |
| 109 | complement activation (GO:0006956) | 3.49157743 |
| 110 | glycerophospholipid catabolic process (GO:0046475) | 3.48961295 |
| 111 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.44711458 |
| 112 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.42614060 |
| 113 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.42614060 |
| 114 | complement activation, classical pathway (GO:0006958) | 3.41985971 |
| 115 | regulation of humoral immune response (GO:0002920) | 3.39736402 |
| 116 | amino acid import (GO:0043090) | 3.38689706 |
| 117 | negative regulation of protein activation cascade (GO:2000258) | 3.36261565 |
| 118 | positive regulation of coagulation (GO:0050820) | 3.36191190 |
| 119 | carnitine metabolic process (GO:0009437) | 3.36108072 |
| 120 | alpha-amino acid catabolic process (GO:1901606) | 3.33703537 |
| 121 | presynaptic membrane organization (GO:0097090) | 3.33529301 |
| 122 | primary alcohol catabolic process (GO:0034310) | 3.33234412 |
| 123 | magnesium ion transport (GO:0015693) | 3.32532058 |
| 124 | arginine metabolic process (GO:0006525) | 3.32311968 |
| 125 | neuron remodeling (GO:0016322) | 3.31990697 |
| 126 | glutamate metabolic process (GO:0006536) | 3.30342819 |
| 127 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.28690953 |
| 128 | xenobiotic metabolic process (GO:0006805) | 3.27774079 |
| 129 | response to redox state (GO:0051775) | 3.27668915 |
| 130 | amyloid precursor protein catabolic process (GO:0042987) | 3.25062280 |
| 131 | response to lead ion (GO:0010288) | 3.23433314 |
| 132 | drug transmembrane transport (GO:0006855) | 3.22220540 |
| 133 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.19771021 |
| 134 | protein palmitoylation (GO:0018345) | 3.18613793 |
| 135 | negative regulation of lipid transport (GO:0032369) | 3.16385059 |
| 136 | phospholipid homeostasis (GO:0055091) | 3.11909714 |
| 137 | monocarboxylic acid catabolic process (GO:0072329) | 3.11381143 |
| 138 | plasma lipoprotein particle clearance (GO:0034381) | 3.11024952 |
| 139 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.10722392 |
| 140 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.09504888 |
| 141 | tyrosine metabolic process (GO:0006570) | 3.09260147 |
| 142 | regulation of bile acid biosynthetic process (GO:0070857) | 3.08018775 |
| 143 | regulation of lipoprotein particle clearance (GO:0010984) | 3.07131445 |
| 144 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.03853187 |
| 145 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 3.02805577 |
| 146 | membrane tubulation (GO:0097320) | 2.99733139 |
| 147 | GPI anchor biosynthetic process (GO:0006506) | 2.99079320 |
| 148 | axon development (GO:0061564) | 2.96602760 |
| 149 | glutathione biosynthetic process (GO:0006750) | 2.95929692 |
| 150 | glycosylceramide metabolic process (GO:0006677) | 2.94681715 |
| 151 | neurotransmitter uptake (GO:0001504) | 2.89050757 |
| 152 | adult walking behavior (GO:0007628) | 2.88975967 |
| 153 | L-phenylalanine catabolic process (GO:0006559) | 2.88451232 |
| 154 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.88451232 |
| 155 | nucleotide transmembrane transport (GO:1901679) | 2.88021092 |
| 156 | heme transport (GO:0015886) | 2.86695189 |
| 157 | glycine transport (GO:0015816) | 2.86155075 |
| 158 | adhesion of symbiont to host cell (GO:0044650) | 2.85366198 |
| 159 | virion attachment to host cell (GO:0019062) | 2.85366198 |
| 160 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.83826477 |
| 161 | presynaptic membrane assembly (GO:0097105) | 2.82650949 |
| 162 | enteric nervous system development (GO:0048484) | 2.82259330 |
| 163 | GPI anchor metabolic process (GO:0006505) | 2.80844896 |
| 164 | iron coordination entity transport (GO:1901678) | 2.77143939 |
| 165 | positive regulation of glial cell differentiation (GO:0045687) | 2.75600245 |
| 166 | acyl-CoA biosynthetic process (GO:0071616) | 2.72632755 |
| 167 | thioester biosynthetic process (GO:0035384) | 2.72632755 |
| 168 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.72456552 |
| 169 | glial cell development (GO:0021782) | 2.71848107 |
| 170 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.66802071 |
| 171 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.66802071 |
| 172 | negative regulation of axonogenesis (GO:0050771) | 2.65146562 |
| 173 | peptide biosynthetic process (GO:0043043) | 2.64377106 |
| 174 | limb bud formation (GO:0060174) | 2.64274090 |
| 175 | positive regulation of gliogenesis (GO:0014015) | 2.63384972 |
| 176 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.62324937 |
| 177 | peptidyl-cysteine modification (GO:0018198) | 2.60201180 |
| 178 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.59089716 |
| 179 | negative regulation of macroautophagy (GO:0016242) | 2.57240698 |
| 180 | negative regulation of JUN kinase activity (GO:0043508) | 2.55576194 |
| 181 | peripheral nervous system development (GO:0007422) | 2.53778000 |
| 182 | Leydig cell differentiation (GO:0033327) | 2.53643883 |
| 183 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.52239777 |
| 184 | nerve growth factor signaling pathway (GO:0038180) | 2.52113890 |
| 185 | negative regulation of chemokine production (GO:0032682) | 2.50349010 |
| 186 | neuron cell-cell adhesion (GO:0007158) | 2.43781410 |
| 187 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.42185640 |
| 188 | glial cell differentiation (GO:0010001) | 2.40763572 |
| 189 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.40136218 |
| 190 | nucleotide transport (GO:0006862) | 2.37089584 |
| 191 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.36738913 |
| 192 | regulation of autophagic vacuole assembly (GO:2000785) | 2.35934213 |
| 193 | extracellular matrix assembly (GO:0085029) | 2.35028628 |
| 194 | neuronal action potential propagation (GO:0019227) | 2.34429831 |
| 195 | organ growth (GO:0035265) | 2.34384255 |
| 196 | axon ensheathment in central nervous system (GO:0032291) | 12.0257273 |
| 197 | central nervous system myelination (GO:0022010) | 12.0257273 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.64400112 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.97438919 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.58301140 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.22477886 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.00487540 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.79292776 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.09237969 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.92006741 |
| 9 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.79458431 |
| 10 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.75581512 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.69889022 |
| 12 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.17399920 |
| 13 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.16410504 |
| 14 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.07792025 |
| 15 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.06937076 |
| 16 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.05616523 |
| 17 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.03627458 |
| 18 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.01632679 |
| 19 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.00895498 |
| 20 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.96496227 |
| 21 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.88849162 |
| 22 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.86769173 |
| 23 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.86616645 |
| 24 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.86616645 |
| 25 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.84667216 |
| 26 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.83498675 |
| 27 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.82411659 |
| 28 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.75324165 |
| 29 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.75013724 |
| 30 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.74487582 |
| 31 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.74334270 |
| 32 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.74178366 |
| 33 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.73402605 |
| 34 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.72340541 |
| 35 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.70849289 |
| 36 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.66912121 |
| 37 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.66691901 |
| 38 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.62939323 |
| 39 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.62483787 |
| 40 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.58970451 |
| 41 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.57119900 |
| 42 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.51904683 |
| 43 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.51236913 |
| 44 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.50210956 |
| 45 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.48924535 |
| 46 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.42018627 |
| 47 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.41986598 |
| 48 | VDR_22108803_ChIP-Seq_LS180_Human | 1.40379306 |
| 49 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.37820371 |
| 50 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.36875717 |
| 51 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.36077218 |
| 52 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.36077218 |
| 53 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.35634959 |
| 54 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.34577726 |
| 55 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.34531911 |
| 56 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.31270414 |
| 57 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.30029951 |
| 58 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.29606590 |
| 59 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.27225741 |
| 60 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.26882283 |
| 61 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.25198773 |
| 62 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.24708262 |
| 63 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.23538049 |
| 64 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.23278030 |
| 65 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.20326123 |
| 66 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.18483910 |
| 67 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.18335559 |
| 68 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.17328255 |
| 69 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.17050847 |
| 70 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.15586998 |
| 71 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.15398570 |
| 72 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.14753929 |
| 73 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.14115606 |
| 74 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.12353636 |
| 75 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.11723144 |
| 76 | P300_19829295_ChIP-Seq_ESCs_Human | 1.11236793 |
| 77 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08982411 |
| 78 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.08723029 |
| 79 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.08397995 |
| 80 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08241988 |
| 81 | * EOMES_21245162_ChIP-Seq_HESCs_Human | 1.08121443 |
| 82 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07889578 |
| 83 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.06506763 |
| 84 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.04066026 |
| 85 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.03582107 |
| 86 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.02828243 |
| 87 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.02201095 |
| 88 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.02200546 |
| 89 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.00032140 |
| 90 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.99300955 |
| 91 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.99300955 |
| 92 | STAT3_23295773_ChIP-Seq_U87_Human | 0.99174442 |
| 93 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.98248252 |
| 94 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.97979330 |
| 95 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97571220 |
| 96 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.97463005 |
| 97 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.97362716 |
| 98 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.97179459 |
| 99 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.96632943 |
| 100 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95976613 |
| 101 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.94770312 |
| 102 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.94122204 |
| 103 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.93884986 |
| 104 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93356574 |
| 105 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.93025408 |
| 106 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.92862186 |
| 107 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.91830567 |
| 108 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.91179019 |
| 109 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.91010123 |
| 110 | CBP_21632823_ChIP-Seq_H3396_Human | 0.89992706 |
| 111 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.89598694 |
| 112 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.89130594 |
| 113 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.88308520 |
| 114 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.88278463 |
| 115 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.86380325 |
| 116 | KDM2B_26808549_Chip-Seq_REH_Human | 0.84937619 |
| 117 | * P300_18555785_Chip-Seq_ESCs_Mouse | 0.83960646 |
| 118 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.83889390 |
| 119 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.83889390 |
| 120 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.83889390 |
| 121 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.83868169 |
| 122 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.83763075 |
| 123 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.83323045 |
| 124 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.83046301 |
| 125 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.82733776 |
| 126 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.82381996 |
| 127 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.81668076 |
| 128 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.81528807 |
| 129 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.81421824 |
| 130 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.81390615 |
| 131 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.81171625 |
| 132 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.81168459 |
| 133 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.80905994 |
| 134 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.78918171 |
| 135 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.78389203 |
| 136 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.76790666 |
| 137 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.76685111 |
| 138 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.76661607 |
| 139 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.76462534 |
| 140 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.76439963 |
| 141 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.76412565 |
| 142 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.75707726 |
| 143 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.75040324 |
| 144 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.74866023 |
| 145 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.73903441 |
| 146 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.73695948 |
| 147 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.73167074 |
| 148 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.73097635 |
| 149 | * SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.72981351 |
| 150 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.72373485 |
| 151 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.72099396 |
| 152 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.72093500 |
| 153 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.71988777 |
| 154 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.71860505 |
| 155 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.71607073 |
| 156 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.71173192 |
| 157 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.70533538 |
| 158 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.70299994 |
| 159 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.69773739 |
| 160 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.69188997 |
| 161 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.68996460 |
| 162 | GATA1_22025678_ChIP-Seq_K562_Human | 0.68492949 |
| 163 | NFYA_21822215_ChIP-Seq_K562_Human | 0.68391402 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.88086405 |
| 2 | MP0000920_abnormal_myelination | 5.93444377 |
| 3 | MP0005365_abnormal_bile_salt | 5.86139592 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.76871104 |
| 5 | MP0005360_urolithiasis | 5.08905556 |
| 6 | MP0002138_abnormal_hepatobiliary_system | 4.32994362 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 4.09740810 |
| 8 | MP0003868_abnormal_feces_composition | 3.92290612 |
| 9 | MP0003252_abnormal_bile_duct | 3.87300901 |
| 10 | MP0003690_abnormal_glial_cell | 3.62764623 |
| 11 | MP0003950_abnormal_plasma_membrane | 3.18007099 |
| 12 | MP0004043_abnormal_pH_regulation | 3.07354496 |
| 13 | MP0003880_abnormal_central_pattern | 3.02778899 |
| 14 | MP0005171_absent_coat_pigmentation | 3.01913134 |
| 15 | MP0004885_abnormal_endolymph | 3.01798285 |
| 16 | MP0003329_amyloid_beta_deposits | 2.97906993 |
| 17 | MP0004742_abnormal_vestibular_system | 2.90001828 |
| 18 | MP0004270_analgesia | 2.81915880 |
| 19 | MP0010329_abnormal_lipoprotein_level | 2.59605320 |
| 20 | MP0003634_abnormal_glial_cell | 2.53590398 |
| 21 | MP0003195_calcinosis | 2.51368307 |
| 22 | MP0001529_abnormal_vocalization | 2.35706893 |
| 23 | MP0003136_yellow_coat_color | 2.35550812 |
| 24 | MP0002272_abnormal_nervous_system | 2.35532393 |
| 25 | MP0001486_abnormal_startle_reflex | 2.25590321 |
| 26 | MP0004142_abnormal_muscle_tone | 2.17678644 |
| 27 | MP0001905_abnormal_dopamine_level | 2.14746492 |
| 28 | MP0001485_abnormal_pinna_reflex | 2.13171638 |
| 29 | MP0009697_abnormal_copulation | 2.08704454 |
| 30 | MP0005410_abnormal_fertilization | 2.02085722 |
| 31 | MP0002876_abnormal_thyroid_physiology | 1.98401049 |
| 32 | MP0008260_abnormal_autophagy | 1.98157143 |
| 33 | MP0002064_seizures | 1.95963322 |
| 34 | MP0005409_darkened_coat_color | 1.93619683 |
| 35 | MP0005058_abnormal_lysosome_morphology | 1.93092293 |
| 36 | MP0004019_abnormal_vitamin_homeostasis | 1.90347427 |
| 37 | MP0002229_neurodegeneration | 1.85832297 |
| 38 | MP0003632_abnormal_nervous_system | 1.83876569 |
| 39 | MP0004147_increased_porphyrin_level | 1.80478449 |
| 40 | MP0000604_amyloidosis | 1.79337341 |
| 41 | MP0000778_abnormal_nervous_system | 1.77521258 |
| 42 | MP0005423_abnormal_somatic_nervous | 1.63725739 |
| 43 | MP0003631_nervous_system_phenotype | 1.61314579 |
| 44 | MP0003633_abnormal_nervous_system | 1.55224417 |
| 45 | MP0010678_abnormal_skin_adnexa | 1.54609997 |
| 46 | MP0002734_abnormal_mechanical_nocicepti | 1.43623045 |
| 47 | MP0004381_abnormal_hair_follicle | 1.43019267 |
| 48 | MP0004134_abnormal_chest_morphology | 1.41210057 |
| 49 | MP0001764_abnormal_homeostasis | 1.41105679 |
| 50 | MP0003191_abnormal_cellular_cholesterol | 1.39639110 |
| 51 | MP0009046_muscle_twitch | 1.37901547 |
| 52 | MP0000609_abnormal_liver_physiology | 1.36376258 |
| 53 | MP0000747_muscle_weakness | 1.36031158 |
| 54 | MP0001661_extended_life_span | 1.33332816 |
| 55 | MP0000462_abnormal_digestive_system | 1.31920096 |
| 56 | MP0009745_abnormal_behavioral_response | 1.31914913 |
| 57 | MP0000383_abnormal_hair_follicle | 1.31895111 |
| 58 | MP0003879_abnormal_hair_cell | 1.29141040 |
| 59 | MP0008569_lethality_at_weaning | 1.28975436 |
| 60 | MP0003635_abnormal_synaptic_transmissio | 1.28213368 |
| 61 | MP0004859_abnormal_synaptic_plasticity | 1.25297281 |
| 62 | MP0005408_hypopigmentation | 1.23528142 |
| 63 | MP0001970_abnormal_pain_threshold | 1.20727948 |
| 64 | MP0001440_abnormal_grooming_behavior | 1.19862591 |
| 65 | MP0000955_abnormal_spinal_cord | 1.19145254 |
| 66 | MP0001963_abnormal_hearing_physiology | 1.18725419 |
| 67 | MP0003806_abnormal_nucleotide_metabolis | 1.18568345 |
| 68 | MP0005451_abnormal_body_composition | 1.15451021 |
| 69 | MP0002066_abnormal_motor_capabilities/c | 1.12797529 |
| 70 | MP0002882_abnormal_neuron_morphology | 1.11387635 |
| 71 | MP0005332_abnormal_amino_acid | 1.11285601 |
| 72 | MP0001756_abnormal_urination | 1.10947998 |
| 73 | MP0001851_eye_inflammation | 1.07782944 |
| 74 | MP0002067_abnormal_sensory_capabilities | 1.06143523 |
| 75 | MP0002572_abnormal_emotion/affect_behav | 1.04706423 |
| 76 | MP0005551_abnormal_eye_electrophysiolog | 1.04686590 |
| 77 | MP0004145_abnormal_muscle_electrophysio | 1.03915676 |
| 78 | MP0005319_abnormal_enzyme/_coenzyme | 1.00767172 |
| 79 | MP0005623_abnormal_meninges_morphology | 0.98669221 |
| 80 | MP0005636_abnormal_mineral_homeostasis | 0.97136384 |
| 81 | MP0003172_abnormal_lysosome_physiology | 0.95882365 |
| 82 | MP0010368_abnormal_lymphatic_system | 0.95315566 |
| 83 | MP0002063_abnormal_learning/memory/cond | 0.93461199 |
| 84 | MP0002733_abnormal_thermal_nociception | 0.89965680 |
| 85 | MP0001299_abnormal_eye_distance/ | 0.89803698 |
| 86 | MP0003878_abnormal_ear_physiology | 0.89746913 |
| 87 | MP0005377_hearing/vestibular/ear_phenot | 0.89746913 |
| 88 | MP0001177_atelectasis | 0.88988704 |
| 89 | MP0002752_abnormal_somatic_nervous | 0.88492107 |
| 90 | MP0001765_abnormal_ion_homeostasis | 0.87905066 |
| 91 | MP0005535_abnormal_body_temperature | 0.87515618 |
| 92 | MP0001958_emphysema | 0.87340773 |
| 93 | MP0003011_delayed_dark_adaptation | 0.86817336 |
| 94 | MP0003656_abnormal_erythrocyte_physiolo | 0.86257114 |
| 95 | MP0001666_abnormal_nutrient_absorption | 0.85494991 |
| 96 | MP0002295_abnormal_pulmonary_circulatio | 0.84964688 |
| 97 | MP0000647_abnormal_sebaceous_gland | 0.84751025 |
| 98 | MP0004924_abnormal_behavior | 0.82150143 |
| 99 | MP0005386_behavior/neurological_phenoty | 0.82150143 |
| 100 | MP0009840_abnormal_foam_cell | 0.82105842 |
| 101 | MP0002971_abnormal_brown_adipose | 0.78875913 |
| 102 | MP0005083_abnormal_biliary_tract | 0.78674828 |
| 103 | MP0008438_abnormal_cutaneous_collagen | 0.78361169 |
| 104 | MP0001984_abnormal_olfaction | 0.76338201 |
| 105 | MP0006082_CNS_inflammation | 0.76123210 |
| 106 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.75023475 |
| 107 | MP0005195_abnormal_posterior_eye | 0.74926496 |
| 108 | MP0000598_abnormal_liver_morphology | 0.74501999 |
| 109 | MP0002168_other_aberrant_phenotype | 0.74298502 |
| 110 | MP0000566_synostosis | 0.73972858 |
| 111 | MP0000003_abnormal_adipose_tissue | 0.72695277 |
| 112 | MP0005670_abnormal_white_adipose | 0.71192412 |
| 113 | MP0009642_abnormal_blood_homeostasis | 0.71072790 |
| 114 | MP0010386_abnormal_urinary_bladder | 0.69559509 |
| 115 | MP0004036_abnormal_muscle_relaxation | 0.69133897 |
| 116 | MP0005645_abnormal_hypothalamus_physiol | 0.67940503 |
| 117 | MP0002638_abnormal_pupillary_reflex | 0.67741452 |
| 118 | MP0001968_abnormal_touch/_nociception | 0.67088922 |
| 119 | MP0004272_abnormal_basement_membrane | 0.66278725 |
| 120 | MP0003638_abnormal_response/metabolism_ | 0.65868062 |
| 121 | MP0003300_gastrointestinal_ulcer | 0.63031838 |
| 122 | MP0003186_abnormal_redox_activity | 0.62869707 |
| 123 | MP0009053_abnormal_anal_canal | 0.62423767 |
| 124 | MP0005388_respiratory_system_phenotype | 0.61843131 |
| 125 | MP0002133_abnormal_respiratory_system | 0.61843131 |
| 126 | MP0005187_abnormal_penis_morphology | 0.61640072 |
| 127 | MP0000749_muscle_degeneration | 0.61159335 |
| 128 | MP0009643_abnormal_urine_homeostasis | 0.60881494 |
| 129 | MP0001915_intracranial_hemorrhage | 0.60801764 |
| 130 | MP0002118_abnormal_lipid_homeostasis | 0.60714854 |
| 131 | MP0000762_abnormal_tongue_morphology | 0.60551134 |
| 132 | MP0000639_abnormal_adrenal_gland | 0.60112774 |
| 133 | MP0008874_decreased_physiological_sensi | 0.60069802 |
| 134 | MP0001727_abnormal_embryo_implantation | 0.59260280 |
| 135 | MP0000026_abnormal_inner_ear | 0.59164259 |
| 136 | MP0003075_altered_response_to | 0.58310293 |
| 137 | MP0002152_abnormal_brain_morphology | 0.57628129 |
| 138 | MP0002090_abnormal_vision | 0.57451503 |
| 139 | MP0002136_abnormal_kidney_physiology | 0.55805069 |
| 140 | MP0002078_abnormal_glucose_homeostasis | 0.54826379 |
| 141 | MP0008872_abnormal_physiological_respon | 0.53642266 |
| 142 | MP0005220_abnormal_exocrine_pancreas | 0.53571999 |
| 143 | MP0002928_abnormal_bile_duct | 0.53389523 |
| 144 | MP0005395_other_phenotype | 0.53234568 |
| 145 | MP0005376_homeostasis/metabolism_phenot | 0.53015720 |
| 146 | MP0005167_abnormal_blood-brain_barrier | 0.49836026 |
| 147 | MP0008469_abnormal_protein_level | 0.49035004 |
| 148 | MP0005166_decreased_susceptibility_to | 0.47750589 |
| 149 | MP0002822_catalepsy | 0.45063056 |
| 150 | MP0009763_increased_sensitivity_to | 0.44966443 |
| 151 | MP0003183_abnormal_peptide_metabolism | 0.44822542 |
| 152 | MP0001501_abnormal_sleep_pattern | 0.43783425 |
| 153 | MP0005646_abnormal_pituitary_gland | 0.43656552 |
| 154 | MP0009764_decreased_sensitivity_to | 0.42234087 |
| 155 | MP0003959_abnormal_lean_body | 0.39006672 |
| 156 | MP0002249_abnormal_larynx_morphology | 0.38525941 |
| 157 | MP0002909_abnormal_adrenal_gland | 0.38347386 |
| 158 | MP0002069_abnormal_eating/drinking_beha | 0.36631671 |
| 159 | MP0003953_abnormal_hormone_level | 0.36471846 |
| 160 | MP0006036_abnormal_mitochondrial_physio | 0.35814109 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 8.42371998 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.94279135 |
| 3 | Complement deficiency (HP:0004431) | 7.34282533 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.69164083 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.66101385 |
| 6 | Neurofibrillary tangles (HP:0002185) | 6.01501209 |
| 7 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 5.91257229 |
| 8 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 5.91257229 |
| 9 | Abnormality of complement system (HP:0005339) | 5.70912726 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 5.64717839 |
| 11 | Conjugated hyperbilirubinemia (HP:0002908) | 4.93289035 |
| 12 | Intrahepatic cholestasis (HP:0001406) | 4.90911977 |
| 13 | Peripheral hypomyelination (HP:0007182) | 4.74331424 |
| 14 | Joint hemorrhage (HP:0005261) | 4.63947410 |
| 15 | Glomerulonephritis (HP:0000099) | 4.57717841 |
| 16 | Onion bulb formation (HP:0003383) | 4.51435998 |
| 17 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 4.42828941 |
| 18 | Abnormal auditory evoked potentials (HP:0006958) | 4.36998868 |
| 19 | Segmental peripheral demyelination/remyelination (HP:0003481) | 4.31444086 |
| 20 | Abnormality of the corticospinal tract (HP:0002492) | 4.27704240 |
| 21 | Increased circulating renin level (HP:0000848) | 4.25181016 |
| 22 | Fat malabsorption (HP:0002630) | 4.22813374 |
| 23 | Cerebral inclusion bodies (HP:0100314) | 4.20016178 |
| 24 | Hyperlipoproteinemia (HP:0010980) | 4.18824915 |
| 25 | Xanthomatosis (HP:0000991) | 4.10483405 |
| 26 | Metabolic alkalosis (HP:0200114) | 4.09456529 |
| 27 | Cerebral hypomyelination (HP:0006808) | 4.06755294 |
| 28 | Hypokalemic alkalosis (HP:0001949) | 4.00583643 |
| 29 | Steatorrhea (HP:0002570) | 3.93195018 |
| 30 | Hypolipoproteinemia (HP:0010981) | 3.92800845 |
| 31 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.89155829 |
| 32 | Hypomagnesemia (HP:0002917) | 3.88100687 |
| 33 | Abnormality of the common coagulation pathway (HP:0010990) | 3.86571420 |
| 34 | Parakeratosis (HP:0001036) | 3.79554280 |
| 35 | Sensory axonal neuropathy (HP:0003390) | 3.77781336 |
| 36 | Hyperglycinemia (HP:0002154) | 3.66684626 |
| 37 | Generalized aminoaciduria (HP:0002909) | 3.56072744 |
| 38 | Supranuclear gaze palsy (HP:0000605) | 3.52082621 |
| 39 | Ankle clonus (HP:0011448) | 3.44029820 |
| 40 | Axonal loss (HP:0003447) | 3.37467363 |
| 41 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.36105916 |
| 42 | Abnormality of glycine metabolism (HP:0010895) | 3.36105916 |
| 43 | Insidious onset (HP:0003587) | 3.30092510 |
| 44 | Termporal pattern (HP:0011008) | 3.30092510 |
| 45 | Hyperglycinuria (HP:0003108) | 3.29785748 |
| 46 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.27885430 |
| 47 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.24493922 |
| 48 | Hyperammonemia (HP:0001987) | 3.18759921 |
| 49 | Rickets (HP:0002748) | 3.17272648 |
| 50 | Nephritis (HP:0000123) | 3.15010089 |
| 51 | Spastic gait (HP:0002064) | 3.14682901 |
| 52 | Spontaneous abortion (HP:0005268) | 3.13932821 |
| 53 | Osteomalacia (HP:0002749) | 3.10704066 |
| 54 | Abnormality of magnesium homeostasis (HP:0004921) | 3.09483194 |
| 55 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.06741878 |
| 56 | Stridor (HP:0010307) | 3.01092680 |
| 57 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.98608519 |
| 58 | Leukodystrophy (HP:0002415) | 2.98547320 |
| 59 | Intention tremor (HP:0002080) | 2.95878742 |
| 60 | Clumsiness (HP:0002312) | 2.88110382 |
| 61 | Slow saccadic eye movements (HP:0000514) | 2.87218240 |
| 62 | Alacrima (HP:0000522) | 2.84165495 |
| 63 | Hyperphosphaturia (HP:0003109) | 2.81984668 |
| 64 | Dysmetria (HP:0001310) | 2.81927596 |
| 65 | Retinal dysplasia (HP:0007973) | 2.70465950 |
| 66 | Glycosuria (HP:0003076) | 2.69620939 |
| 67 | Abnormality of urine glucose concentration (HP:0011016) | 2.69620939 |
| 68 | Increased serum pyruvate (HP:0003542) | 2.68707592 |
| 69 | Abnormality of glycolysis (HP:0004366) | 2.68707592 |
| 70 | Abnormality of the intrinsic pathway (HP:0010989) | 2.68158791 |
| 71 | Hypoplasia of the iris (HP:0007676) | 2.66733195 |
| 72 | CNS hypomyelination (HP:0003429) | 2.65869979 |
| 73 | Abnormality of nucleobase metabolism (HP:0010932) | 2.61181981 |
| 74 | Scanning speech (HP:0002168) | 2.59674825 |
| 75 | Gout (HP:0001997) | 2.59075244 |
| 76 | Proximal tubulopathy (HP:0000114) | 2.58400638 |
| 77 | Spastic paraparesis (HP:0002313) | 2.57747810 |
| 78 | Myokymia (HP:0002411) | 2.56094008 |
| 79 | Peripheral demyelination (HP:0011096) | 2.53380362 |
| 80 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.50492665 |
| 81 | Premature skin wrinkling (HP:0100678) | 2.46142917 |
| 82 | Hypercholesterolemia (HP:0003124) | 2.44734392 |
| 83 | Hypoplastic pelvis (HP:0008839) | 2.43937686 |
| 84 | Vascular calcification (HP:0004934) | 2.43906764 |
| 85 | Mitral stenosis (HP:0001718) | 2.41048717 |
| 86 | Epidermoid cyst (HP:0200040) | 2.41041506 |
| 87 | Hypoalphalipoproteinemia (HP:0003233) | 2.40895635 |
| 88 | Abnormality of serum amino acid levels (HP:0003112) | 2.40353019 |
| 89 | Delayed CNS myelination (HP:0002188) | 2.36025188 |
| 90 | Abnormality of vitamin metabolism (HP:0100508) | 2.35601644 |
| 91 | Cerebral hemorrhage (HP:0001342) | 2.35377155 |
| 92 | Hyperactive renin-angiotensin system (HP:0000841) | 2.34600023 |
| 93 | Sensorimotor neuropathy (HP:0007141) | 2.33966678 |
| 94 | Foot dorsiflexor weakness (HP:0009027) | 2.33059735 |
| 95 | Pheochromocytoma (HP:0002666) | 2.32332765 |
| 96 | Renal salt wasting (HP:0000127) | 2.32161061 |
| 97 | Morphological abnormality of the inner ear (HP:0011390) | 2.31352270 |
| 98 | Polyuria (HP:0000103) | 2.31220158 |
| 99 | White forelock (HP:0002211) | 2.31141333 |
| 100 | Abnormal urine phosphate concentration (HP:0012599) | 2.30633852 |
| 101 | Abnormality of purine metabolism (HP:0004352) | 2.30609566 |
| 102 | Patchy hypopigmentation of hair (HP:0011365) | 2.29587896 |
| 103 | Abnormal drinking behavior (HP:0030082) | 2.29245207 |
| 104 | Polydipsia (HP:0001959) | 2.29245207 |
| 105 | Autoamputation (HP:0001218) | 2.27749984 |
| 106 | Diaphragmatic weakness (HP:0009113) | 2.27409807 |
| 107 | Spastic tetraparesis (HP:0001285) | 2.23888964 |
| 108 | Hepatosplenomegaly (HP:0001433) | 2.23837075 |
| 109 | Decreased lacrimation (HP:0000633) | 2.21715044 |
| 110 | Irritability (HP:0000737) | 2.20396681 |
| 111 | Absent septum pellucidum (HP:0001331) | 2.15703914 |
| 112 | Paraparesis (HP:0002385) | 2.12908194 |
| 113 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.11614531 |
| 114 | Hypokalemia (HP:0002900) | 2.11336060 |
| 115 | Abnormality of methionine metabolism (HP:0010901) | 2.09944494 |
| 116 | Abnormality of the foot musculature (HP:0001436) | 2.09636518 |
| 117 | Cholecystitis (HP:0001082) | 2.09436170 |
| 118 | Abnormal gallbladder physiology (HP:0012438) | 2.09436170 |
| 119 | Anteriorly placed anus (HP:0001545) | 2.09241776 |
| 120 | Hydroxyprolinuria (HP:0003080) | 2.09167384 |
| 121 | Abnormality of proline metabolism (HP:0010907) | 2.09167384 |
| 122 | Abnormal urine output (HP:0012590) | 2.09094357 |
| 123 | Decreased motor nerve conduction velocity (HP:0003431) | 2.07864962 |
| 124 | Bifid scrotum (HP:0000048) | 2.07271739 |
| 125 | Muscle fiber splitting (HP:0003555) | 2.06781835 |
| 126 | Clonus (HP:0002169) | 2.06645392 |
| 127 | Cardiovascular calcification (HP:0011915) | 2.05342056 |
| 128 | Gingival bleeding (HP:0000225) | 2.04448473 |
| 129 | Hemorrhage of the eye (HP:0011885) | 2.03400574 |
| 130 | Gonadal dysgenesis (HP:0000133) | 2.02713624 |
| 131 | Neuroendocrine neoplasm (HP:0100634) | 2.00984320 |
| 132 | Metabolic acidosis (HP:0001942) | 2.00938748 |
| 133 | Abnormality of chloride homeostasis (HP:0011422) | 2.00931828 |
| 134 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.99277158 |
| 135 | Abnormality of renal excretion (HP:0011036) | 1.99002735 |
| 136 | Alkalosis (HP:0001948) | 1.98395077 |
| 137 | Hyperaldosteronism (HP:0000859) | 1.98324315 |
| 138 | Hypophosphatemic rickets (HP:0004912) | 1.97862994 |
| 139 | Abnormality of renin-angiotensin system (HP:0000847) | 1.97455530 |
| 140 | Methylmalonic acidemia (HP:0002912) | 1.97063359 |
| 141 | Elevated alkaline phosphatase (HP:0003155) | 1.96372521 |
| 142 | Hammertoe (HP:0001765) | 1.93933260 |
| 143 | Neonatal onset (HP:0003623) | 1.93780129 |
| 144 | Hyperbilirubinemia (HP:0002904) | 1.93484542 |
| 145 | Poor speech (HP:0002465) | 1.92266945 |
| 146 | Action tremor (HP:0002345) | 1.91272130 |
| 147 | Lower limb muscle weakness (HP:0007340) | 1.90849151 |
| 148 | Thickened helices (HP:0000391) | 1.89850200 |
| 149 | Reduced antithrombin III activity (HP:0001976) | 1.89553677 |
| 150 | Akinesia (HP:0002304) | 1.88911581 |
| 151 | Split foot (HP:0001839) | 1.88239932 |
| 152 | Atrioventricular block (HP:0001678) | 1.87390833 |
| 153 | Distal sensory impairment (HP:0002936) | 1.86689727 |
| 154 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.86007498 |
| 155 | Vacuolated lymphocytes (HP:0001922) | 1.85129412 |
| 156 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.84169663 |
| 157 | Confusion (HP:0001289) | 1.83195469 |
| 158 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.83015377 |
| 159 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.81518294 |
| 160 | Choreoathetosis (HP:0001266) | 1.80248197 |
| 161 | Potter facies (HP:0002009) | 1.79567585 |
| 162 | Facial shape deformation (HP:0011334) | 1.79567585 |
| 163 | Purpura (HP:0000979) | 1.79377536 |
| 164 | Urinary incontinence (HP:0000020) | 1.78397947 |
| 165 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.77279161 |
| 166 | Abnormality of the septum pellucidum (HP:0007375) | 1.75834113 |
| 167 | Ulnar claw (HP:0001178) | 1.75042128 |
| 168 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.74160984 |
| 169 | Hypoplasia of the uterus (HP:0000013) | 1.73217132 |
| 170 | Neuronal loss in central nervous system (HP:0002529) | 1.73010290 |
| 171 | Urinary urgency (HP:0000012) | 1.72578280 |
| 172 | Arthropathy (HP:0003040) | 1.71969491 |
| 173 | Hypophosphatemia (HP:0002148) | 1.69341499 |
| 174 | Abnormality of the Achilles tendon (HP:0005109) | 1.69229009 |
| 175 | Partial agenesis of the corpus callosum (HP:0001338) | 1.69163112 |
| 176 | Progressive neurologic deterioration (HP:0002344) | 1.68902879 |
| 177 | Retinal atrophy (HP:0001105) | 1.68515763 |
| 178 | Cholelithiasis (HP:0001081) | 1.67949860 |
| 179 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.67872977 |
| 180 | Thrombophlebitis (HP:0004418) | 1.67708875 |
| 181 | Fair hair (HP:0002286) | 1.67678517 |
| 182 | Pulmonary embolism (HP:0002204) | 1.67233793 |
| 183 | Prolonged neonatal jaundice (HP:0006579) | 1.67093047 |
| 184 | Abnormal gallbladder morphology (HP:0012437) | 1.66678875 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 6.53212166 |
| 2 | OXSR1 | 5.14531758 |
| 3 | EPHB1 | 3.79951098 |
| 4 | WNK4 | 3.71103892 |
| 5 | MAPKAPK5 | 3.11918848 |
| 6 | NTRK3 | 2.99904391 |
| 7 | PKN1 | 2.85605242 |
| 8 | RIPK1 | 2.78668487 |
| 9 | SGK2 | 2.42436902 |
| 10 | PBK | 2.37817842 |
| 11 | WNK1 | 2.17103085 |
| 12 | LIMK1 | 2.11046722 |
| 13 | NEK9 | 2.00890014 |
| 14 | MET | 2.00295547 |
| 15 | PIK3CG | 1.93297383 |
| 16 | BCR | 1.93054817 |
| 17 | WNK3 | 1.79943759 |
| 18 | SGK3 | 1.77834381 |
| 19 | UHMK1 | 1.76894087 |
| 20 | TESK2 | 1.74934043 |
| 21 | FGFR2 | 1.70570911 |
| 22 | SGK494 | 1.69859043 |
| 23 | SGK223 | 1.69859043 |
| 24 | NTRK1 | 1.64878820 |
| 25 | CSNK1G3 | 1.62251346 |
| 26 | CSNK1A1L | 1.61963490 |
| 27 | CDK19 | 1.55204889 |
| 28 | FGFR4 | 1.50304698 |
| 29 | NEK6 | 1.48293461 |
| 30 | ERN1 | 1.46937825 |
| 31 | CLK1 | 1.45614581 |
| 32 | LMTK2 | 1.45485026 |
| 33 | PNCK | 1.44073101 |
| 34 | CAMK2B | 1.43808769 |
| 35 | TYRO3 | 1.40616028 |
| 36 | DAPK2 | 1.39087314 |
| 37 | OBSCN | 1.36277587 |
| 38 | ROCK2 | 1.35823992 |
| 39 | EPHA3 | 1.34617981 |
| 40 | TNIK | 1.33021260 |
| 41 | PRKCG | 1.29408874 |
| 42 | CSNK1G1 | 1.25367317 |
| 43 | PRKACG | 1.23219782 |
| 44 | CSNK1G2 | 1.18101651 |
| 45 | MST4 | 1.16648421 |
| 46 | CAMK2D | 1.14620163 |
| 47 | CASK | 1.13654974 |
| 48 | MAPK15 | 1.11371488 |
| 49 | FGR | 1.09197966 |
| 50 | MOS | 1.08691991 |
| 51 | SGK1 | 1.02727016 |
| 52 | CAMKK1 | 1.02501355 |
| 53 | MUSK | 0.96630520 |
| 54 | MAP2K2 | 0.94222644 |
| 55 | PRPF4B | 0.93594825 |
| 56 | DYRK2 | 0.92334578 |
| 57 | MAPK7 | 0.92002624 |
| 58 | CAMK2G | 0.89963928 |
| 59 | MAP3K9 | 0.88259113 |
| 60 | PAK6 | 0.88241965 |
| 61 | FGFR3 | 0.84526304 |
| 62 | ICK | 0.81739477 |
| 63 | PIM2 | 0.80931032 |
| 64 | IRAK2 | 0.80251668 |
| 65 | PHKG1 | 0.77880353 |
| 66 | PHKG2 | 0.77880353 |
| 67 | PRKD1 | 0.77589372 |
| 68 | CAMK1G | 0.77223370 |
| 69 | MARK1 | 0.74942935 |
| 70 | PRKAA2 | 0.73021103 |
| 71 | PRKCQ | 0.72566786 |
| 72 | PRKD3 | 0.71588105 |
| 73 | ERBB2 | 0.71367318 |
| 74 | MARK2 | 0.70444728 |
| 75 | GSK3A | 0.69833429 |
| 76 | PDPK1 | 0.69091011 |
| 77 | CAMK2A | 0.68285327 |
| 78 | RPS6KA3 | 0.68118687 |
| 79 | CDK5 | 0.68026038 |
| 80 | PRKCZ | 0.67827288 |
| 81 | MINK1 | 0.67658685 |
| 82 | CDK14 | 0.66555829 |
| 83 | PAK3 | 0.65020815 |
| 84 | FES | 0.64770480 |
| 85 | BMPR1B | 0.64415566 |
| 86 | JAK1 | 0.64347710 |
| 87 | PRKCE | 0.64044558 |
| 88 | BCKDK | 0.62496591 |
| 89 | TNK2 | 0.62062211 |
| 90 | GRK7 | 0.61673065 |
| 91 | PRKAA1 | 0.60701400 |
| 92 | ABL2 | 0.60407417 |
| 93 | MAP3K13 | 0.59049885 |
| 94 | BLK | 0.58469231 |
| 95 | RPS6KA5 | 0.58399601 |
| 96 | MAPK11 | 0.57967678 |
| 97 | DYRK1B | 0.57762987 |
| 98 | CAMKK2 | 0.55202166 |
| 99 | CDK15 | 0.55191788 |
| 100 | ACVR1B | 0.55037897 |
| 101 | MAP2K4 | 0.54739576 |
| 102 | JAK2 | 0.54512482 |
| 103 | TBK1 | 0.53366258 |
| 104 | TRPM7 | 0.53193120 |
| 105 | PRKCA | 0.53111830 |
| 106 | FYN | 0.52809539 |
| 107 | EPHA4 | 0.52619445 |
| 108 | MAPK13 | 0.52555312 |
| 109 | KSR2 | 0.51431803 |
| 110 | MAP3K1 | 0.51377784 |
| 111 | PIK3CA | 0.51197950 |
| 112 | MAP3K12 | 0.51189324 |
| 113 | MAPK10 | 0.50956028 |
| 114 | IGF1R | 0.49918661 |
| 115 | CDK18 | 0.49413890 |
| 116 | CDK11A | 0.49009143 |
| 117 | PRKACB | 0.48517026 |
| 118 | ROCK1 | 0.47442971 |
| 119 | FER | 0.46369712 |
| 120 | BMPR2 | 0.45892656 |
| 121 | PINK1 | 0.45566998 |
| 122 | RET | 0.45491286 |
| 123 | MAPK4 | 0.44202657 |
| 124 | PRKCB | 0.43898381 |
| 125 | MAP3K2 | 0.43804512 |
| 126 | CAMK4 | 0.43537823 |
| 127 | IRAK1 | 0.42797269 |
| 128 | PRKG1 | 0.41196007 |
| 129 | MAP3K5 | 0.41171614 |
| 130 | PTK2B | 0.40972267 |
| 131 | CSNK1A1 | 0.40020184 |
| 132 | ADRBK2 | 0.37892564 |
| 133 | CSNK1D | 0.37591866 |
| 134 | MKNK1 | 0.36840395 |
| 135 | PDK1 | 0.36383634 |
| 136 | DMPK | 0.35976547 |
| 137 | PDGFRB | 0.35185280 |
| 138 | NTRK2 | 0.34228931 |
| 139 | PRKCH | 0.33250867 |
| 140 | PAK2 | 0.33184420 |
| 141 | ITK | 0.32134198 |
| 142 | PAK1 | 0.29644638 |
| 143 | DAPK3 | 0.28314482 |
| 144 | GRK1 | 0.28054004 |
| 145 | DYRK1A | 0.27650288 |
| 146 | PRKACA | 0.27449788 |
| 147 | PDK2 | 0.26985567 |
| 148 | INSR | 0.25730838 |
| 149 | CAMK1D | 0.23815444 |
| 150 | ARAF | 0.23511149 |
| 151 | MAPK12 | 0.22496689 |
| 152 | CSK | 0.22303845 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.98958848 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.47891545 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.36980769 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.96260774 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.71431308 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.66653802 |
| 7 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.55090439 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.37709635 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.23246381 |
| 10 | Retinol metabolism_Homo sapiens_hsa00830 | 3.09496353 |
| 11 | Ether lipid metabolism_Homo sapiens_hsa00565 | 3.00237955 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.91406665 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.76219665 |
| 14 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.59530552 |
| 15 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.46775142 |
| 16 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.38199619 |
| 17 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.30802890 |
| 18 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.27022899 |
| 19 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.21080336 |
| 20 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.17420887 |
| 21 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.08557712 |
| 22 | Protein export_Homo sapiens_hsa03060 | 2.01460957 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.97020855 |
| 24 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.90259901 |
| 25 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.81627026 |
| 26 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.76514503 |
| 27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.71920757 |
| 28 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.65862565 |
| 29 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.63137040 |
| 30 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.58559911 |
| 31 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.57817139 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.56768953 |
| 33 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.53344803 |
| 34 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.46147443 |
| 35 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.36495443 |
| 36 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.31354747 |
| 37 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.30761270 |
| 38 | Axon guidance_Homo sapiens_hsa04360 | 1.28099620 |
| 39 | * Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.19076563 |
| 40 | Lysosome_Homo sapiens_hsa04142 | 1.18058103 |
| 41 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.14165977 |
| 42 | Parkinsons disease_Homo sapiens_hsa05012 | 1.13472511 |
| 43 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.11514516 |
| 44 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.10868102 |
| 45 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.08335791 |
| 46 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.06146090 |
| 47 | Alzheimers disease_Homo sapiens_hsa05010 | 1.04941362 |
| 48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.01020388 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.00960087 |
| 50 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.99700761 |
| 51 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.98564214 |
| 52 | Carbon metabolism_Homo sapiens_hsa01200 | 0.98259198 |
| 53 | Mineral absorption_Homo sapiens_hsa04978 | 0.97584573 |
| 54 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.97555840 |
| 55 | * Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.93648687 |
| 56 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.93272216 |
| 57 | GABAergic synapse_Homo sapiens_hsa04727 | 0.93100253 |
| 58 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.91357130 |
| 59 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.88852852 |
| 60 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.87478904 |
| 61 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.86867431 |
| 62 | Peroxisome_Homo sapiens_hsa04146 | 0.86456444 |
| 63 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.85255539 |
| 64 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.82031722 |
| 65 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.81178132 |
| 66 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.80880775 |
| 67 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.79506072 |
| 68 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79277830 |
| 69 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.79255929 |
| 70 | Long-term depression_Homo sapiens_hsa04730 | 0.72644656 |
| 71 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.70279552 |
| 72 | ABC transporters_Homo sapiens_hsa02010 | 0.70153438 |
| 73 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.68140676 |
| 74 | Cocaine addiction_Homo sapiens_hsa05030 | 0.66373538 |
| 75 | Other glycan degradation_Homo sapiens_hsa00511 | 0.66250430 |
| 76 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.65690334 |
| 77 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.65356456 |
| 78 | Phagosome_Homo sapiens_hsa04145 | 0.64383694 |
| 79 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.64228015 |
| 80 | Tight junction_Homo sapiens_hsa04530 | 0.64168577 |
| 81 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.62825549 |
| 82 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.62062599 |
| 83 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.62039381 |
| 84 | Morphine addiction_Homo sapiens_hsa05032 | 0.61868255 |
| 85 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.61474434 |
| 86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60591942 |
| 87 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.59931280 |
| 88 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.59518699 |
| 89 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.58512001 |
| 90 | Endocytosis_Homo sapiens_hsa04144 | 0.57748525 |
| 91 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57261561 |
| 92 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.57244320 |
| 93 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.56456750 |
| 94 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.56196203 |
| 95 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.53380638 |
| 96 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.53150496 |
| 97 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.53017761 |
| 98 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.52845676 |
| 99 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.52331091 |
| 100 | Lysine degradation_Homo sapiens_hsa00310 | 0.50507023 |
| 101 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.50364886 |
| 102 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.50299829 |
| 103 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.49443500 |
| 104 | Salivary secretion_Homo sapiens_hsa04970 | 0.48851763 |
| 105 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.47505655 |
| 106 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.46186616 |
| 107 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.43808555 |
| 108 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.43223895 |
| 109 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.42648821 |
| 110 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.41822088 |
| 111 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.40044685 |
| 112 | Prion diseases_Homo sapiens_hsa05020 | 0.38430295 |
| 113 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.34216576 |
| 114 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.33161508 |
| 115 | Huntingtons disease_Homo sapiens_hsa05016 | 0.32925344 |
| 116 | Circadian entrainment_Homo sapiens_hsa04713 | 0.32917155 |
| 117 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.31941290 |
| 118 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31779496 |
| 119 | Renin secretion_Homo sapiens_hsa04924 | 0.31457767 |
| 120 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.31367698 |
| 121 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.31305773 |
| 122 | Bile secretion_Homo sapiens_hsa04976 | 0.30533591 |
| 123 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.29190123 |
| 124 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.28802118 |
| 125 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.28736506 |
| 126 | Gap junction_Homo sapiens_hsa04540 | 0.28263800 |
| 127 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.25868320 |
| 128 | Sulfur relay system_Homo sapiens_hsa04122 | 0.24793239 |
| 129 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.24393160 |
| 130 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.23992485 |
| 131 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.22931574 |
| 132 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.19711347 |
| 133 | Pertussis_Homo sapiens_hsa05133 | 0.18888529 |
| 134 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.16185110 |
| 135 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.14891537 |
| 136 | Galactose metabolism_Homo sapiens_hsa00052 | 0.13129338 |
| 137 | Insulin resistance_Homo sapiens_hsa04931 | 0.05362702 |
| 138 | Circadian rhythm_Homo sapiens_hsa04710 | 0.05107227 |
| 139 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.04245075 |
| 140 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.03596179 |
| 141 | Insulin secretion_Homo sapiens_hsa04911 | 0.03040883 |
| 142 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.02013768 |
| 143 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.00346856 |
| 144 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | -0.0533727 |
| 145 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0381464 |

